NSUN2 and colorectal carcinoma: Furthermore, although we succeeded in demonstrating an association between high NSUN2 expression and sensitivity to lapatinib in CRC, this association needs to be further validated based on correlations between the clinical levels of NSUN2 expression and the therapeutic efficacy of lapatinib, cetuximab or herceptin.